Literature DB >> 25604751

The unexpected increase of clotrimazole apparent solubility using randomly methylated β-cyclodextrin.

Bénédicte Pradines1, Jean-François Gallard, Bogdan I Iorga, Claire Gueutin, Gilles Ponchel, Philippe M Loiseau, Kawthar Bouchemal.   

Abstract

Clotrimazole (CTZ) and cyclodextrin (CD) inclusion complexes having improved apparent water solubility were obtained from phase solubility diagrams. β-CD (1.5% w/w) and hydroxypropyl-β-CD (40% w/w) offered poor CTZ solubility enhancements (12 and 384 times, respectively). Unexpectedly, the apparent solubility of CTZ was 9980 times increased from 0.4 µg.mL(-1) (1.42 μM) without CD to 4.89 mg.mL(-1) (14.9 mM) using randomly-methylated β-CD (Me-β-CD) (40% w/w). This is the highest apparent CTZ solubility improvement ever reported in the literature using conventional CDs. Quantitative nuclear magnetic resonance ((1) H-NMR) coupled with two-dimensional nuclear Overhauser effect (NOESY) experiments and molecular docking calculations showed that the highest interactions with Me-β-CD were reported for CTZ two phenyl groups. A lower interaction was reported for chlorophenyl, while imidazole had the weakest interaction with Me-β-CD.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bidimensionnal 1H-RMN; clotrimazole; cyclodextrins; molecular docking; solubilization

Mesh:

Substances:

Year:  2015        PMID: 25604751     DOI: 10.1002/jmr.2432

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  2 in total

Review 1.  Strategies for Prevention and Treatment of Trichomonas vaginalis Infections.

Authors:  Kawthar Bouchemal; Christian Bories; Philippe M Loiseau
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Mucoadhesive Poloxamer-Based Hydrogels for the Release of HP-β-CD-Complexed Dexamethasone in the Treatment of Buccal Diseases.

Authors:  Raul Diaz-Salmeron; Balthazar Toussaint; Nicolas Huang; Etienne Bourgeois Ducournau; Gabriel Alviset; Sophie Goulay Dufaÿ; Hervé Hillaireau; Amélie Dufaÿ Wojcicki; Vincent Boudy
Journal:  Pharmaceutics       Date:  2021-01-18       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.